Radiotherapy Market by Product (LINAC, CyberKnife, Gamma Knife, Tomotherapy, Particle Therapy, Cyclotron), Procedure (External (IMRT, IGRT, 3D-CRT) Internal (LDR, HDR)), Application (Prostate, Breast, Lung), End User (Hospitals) - Global Forecasts to 2026
The global radiotherapy market is valued at USD 5.9 billion in 2021 and is expected to reach USD 7.3 billion by 2026, at a CAGR of 4.2% during the forecast period. The growth of this market is primarily driven by the rising burden of target diseases and increasing investments, funds, and grants for the development of novel products. Additionally, the growing adoption of radiotherapy procedures for cancer treatment, increasing use of particle therapy for cancer treatment, and the rising number of conferences and symposia focusing on the advancements in radiotherapy are some of the other major factors driving the growth of this market. However, the underdeveloped public health infrastructure in emerging countries, shortage of trained and skilled radiation oncologists, and the limited access to and affordability of various radiotherapy treatment options are the major factors that are expected to restrain the growth of this market during the forecast period.
“The prostate cancer segment, by application, accounted for the largest share of the external beam as well as internal beamradiotherapymarket in 2020”
On the basis of application, the radiotherapy market is classified into two major segments—external beam radiotherapy and internal beam radiotherapy/brachytherapy applications. Based on indication, the external beam radiotherapy applications segment is further divided into prostate cancer, breast cancer, lung cancer, colorectal cancer, head and neck cancer (laryngeal cancer, hypopharyngeal cancer, oropharyngeal cancer, and oral cavity cancer), and other cancers (pancreatic cancer, brain cancer, and gastrointestinal cancer, among others). The prostate cancer segment accounted for a significant share of both EBRT and brachytherapy market owing to the high and growing prevalence of prostate cancer and the positive outcomes for prostate cancer treatment usingradiotherapy.
“The particle therapy segment ofproduct, to register a significant growth rate amongst the external beam radiotherapy products, owing to new product launches and approvals”
On the basis of product, the radiotherapy market is segmented into external beam radiotherapy, internal beam radiotherapy/brachytherapy, and systemic radiotherapy products. The external beam radiotherapy products segment is further divided into linear accelerators, particle therapy systems, and conventional cobalt-60 teletherapy units. The internal beam radiotherapy/brachytherapy products segment includes seeds, applicators, afterloaders, and IORT systems, while the systemic radiotherapy segment includes iobenguane (I-131), samarium-153, rhenium-186, and other radioisotopes (Yttrium-90, Radium-223, Phosphorous-32, and Radio-labelled antibodies, among others). In 2020, the particle therapy segment accounted for the largest growth rate, mainly due to the growing prevalence of cancer, continuous product development, and launches during last three years. For instance, Varian launched the ProBeam 360° single-room proton therapy system in 2018 and introduced a multi-room configuration for the same product in 2019. Similarly, Mevion received FDA 510(k) clearance for the MEVION S250i Proton Therapy System, including the HYPERSCAN pencil beam scanning (PBS) technology, in January 2018.
“Increasedinstallations and government initiativesto drive the segment growthof hospitals end user segment”
Based on end user, the radiotherapy market has been segmented into hospitals and independent radiotherapy centers. The hospitals segment accounted for the largest share of the radiotherapy market owing to the rising global prevalence of cancer, increasing installations of advanced radiotherapy equipment in developed as well as developing regions, increasing government initiatives aimed at equipping (or upgrading) hospitals with newer and advanced radiotherapy systems, and the increasing availability of funding for the adoption of advanced cancer treatment technologies.In 2021, Children’s Hospital of Fudan University, Shanghai and Shanghai Fosun Healthcare (Group) Co., Ltd. (China) signed an agreement with Mevion Medical Systems to establish the first pediatric proton therapy center in China. Many more such recent developments will drive the market for hospital end user segment.
“The US market, by region, commanded the largest market share in 2020”
On the basis of region, the radiotherapy market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The North America held the major share of the global radiotherapy market in 2020. The large share of the North American market can be attributed to factors such as the ongoing technological advancements, rising incidence of cancer, improving reimbursement scenario, and the rising focus of key players on strengthening their presence in the region.
A breakdown of the primary participants referred to for this report is provided below:
Research Coverage
This report studies the radiotherapymarket based onproduct, procedure, application, end user, and region. It also coversthe factors affecting market growth,analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.
This report provides insights on the following pointers:
“The prostate cancer segment, by application, accounted for the largest share of the external beam as well as internal beamradiotherapymarket in 2020”
On the basis of application, the radiotherapy market is classified into two major segments—external beam radiotherapy and internal beam radiotherapy/brachytherapy applications. Based on indication, the external beam radiotherapy applications segment is further divided into prostate cancer, breast cancer, lung cancer, colorectal cancer, head and neck cancer (laryngeal cancer, hypopharyngeal cancer, oropharyngeal cancer, and oral cavity cancer), and other cancers (pancreatic cancer, brain cancer, and gastrointestinal cancer, among others). The prostate cancer segment accounted for a significant share of both EBRT and brachytherapy market owing to the high and growing prevalence of prostate cancer and the positive outcomes for prostate cancer treatment usingradiotherapy.
“The particle therapy segment ofproduct, to register a significant growth rate amongst the external beam radiotherapy products, owing to new product launches and approvals”
On the basis of product, the radiotherapy market is segmented into external beam radiotherapy, internal beam radiotherapy/brachytherapy, and systemic radiotherapy products. The external beam radiotherapy products segment is further divided into linear accelerators, particle therapy systems, and conventional cobalt-60 teletherapy units. The internal beam radiotherapy/brachytherapy products segment includes seeds, applicators, afterloaders, and IORT systems, while the systemic radiotherapy segment includes iobenguane (I-131), samarium-153, rhenium-186, and other radioisotopes (Yttrium-90, Radium-223, Phosphorous-32, and Radio-labelled antibodies, among others). In 2020, the particle therapy segment accounted for the largest growth rate, mainly due to the growing prevalence of cancer, continuous product development, and launches during last three years. For instance, Varian launched the ProBeam 360° single-room proton therapy system in 2018 and introduced a multi-room configuration for the same product in 2019. Similarly, Mevion received FDA 510(k) clearance for the MEVION S250i Proton Therapy System, including the HYPERSCAN pencil beam scanning (PBS) technology, in January 2018.
“Increasedinstallations and government initiativesto drive the segment growthof hospitals end user segment”
Based on end user, the radiotherapy market has been segmented into hospitals and independent radiotherapy centers. The hospitals segment accounted for the largest share of the radiotherapy market owing to the rising global prevalence of cancer, increasing installations of advanced radiotherapy equipment in developed as well as developing regions, increasing government initiatives aimed at equipping (or upgrading) hospitals with newer and advanced radiotherapy systems, and the increasing availability of funding for the adoption of advanced cancer treatment technologies.In 2021, Children’s Hospital of Fudan University, Shanghai and Shanghai Fosun Healthcare (Group) Co., Ltd. (China) signed an agreement with Mevion Medical Systems to establish the first pediatric proton therapy center in China. Many more such recent developments will drive the market for hospital end user segment.
“The US market, by region, commanded the largest market share in 2020”
On the basis of region, the radiotherapy market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The North America held the major share of the global radiotherapy market in 2020. The large share of the North American market can be attributed to factors such as the ongoing technological advancements, rising incidence of cancer, improving reimbursement scenario, and the rising focus of key players on strengthening their presence in the region.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type:Tier 1–45%, Tier 2–34%, and Tier 3– 21%
- By Designation: C-level–47%, Director-level–33%, and Others–20%
- By Region:North America–35%, Europe–32%, Asia Pacific–25%, Latin America–6%, and the Middle East & Africa–2%
Research Coverage
This report studies the radiotherapymarket based onproduct, procedure, application, end user, and region. It also coversthe factors affecting market growth,analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.
This report provides insights on the following pointers:
- Market Penetration:Comprehensive information on the product portfolios offered by the top players in the radiotherapymarket
- Product Development/Innovation:Detailed insights on the upcoming trends, R&D activities, and product launches in the radiotherapymarket
- Market Development:Comprehensive information on lucrative emerging regions
- Market Diversification:Exhaustive information about new products, growing geographies, and recent developments in the radiotherapymarket
- Competitive Assessment:In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY USED FOR THE STUDY
1.5 MARKET STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 2 BREAKDOWN OF PRIMARIES: RADIOTHERAPY MARKET
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
2.2.2 USAGE-BASED MARKET ESTIMATION
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: GLOBAL RADIOTHERAPY MARKET
2.2.3 PRIMARY RESEARCH VALIDATION
2.3 DATA TRIANGULATION
FIGURE 5 DATA TRIANGULATION
2.4 RESEARCH ASSUMPTIONS
2.5 RESEARCH LIMITATIONS
3 EXECUTIVE SUMMARY
FIGURE 6 RADIOTHERAPY MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
FIGURE 7 EXTERNAL BEAM RADIOTHERAPY MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
FIGURE 8 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PROCEDURE, 2021 VS. 2026 (USD MILLION)
FIGURE 9 RADIOTHERAPY MARKET SHARE, BY END USER, 2021 VS. 2026
FIGURE 10 GEOGRAPHICAL SNAPSHOT OF THE RADIOTHERAPY MARKET
4 PREMIUM INSIGHTS
4.1 RADIOTHERAPY MARKET OVERVIEW
FIGURE 11 RISING CANCER PREVALENCE ACROSS THE GLOBE TO DRIVE THE
GROWTH OF THE RADIOTHERAPY MARKET
4.2 EUROPE: EXTERNAL BEAM RADIOTHERAPY MARKET, BY PRODUCT AND REGION
FIGURE 12 LINER ACCELERATORS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE
OF THE EUROPEAN MARKET
4.3 NORTH AMERICA: INTERNAL BEAM RADIOTHERAPY MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
FIGURE 13 PROSTATE CANCER TREATMENT IS THE LARGEST APPLICATION OF
INTERNAL BEAM RADIOTHERAPY IN NORTH AMERICA
4.4 GEOGRAPHIC SNAPSHOT OF THE RADIOTHERAPY MARKET
FIGURE 14 CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 15 RADIOTHERAPY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Technological advancements
5.2.1.2 Expansion of the target patient population
5.2.1.3 Increasing number of conferences and symposia focusing on spreading awareness about the benefits of radiotherapy
5.2.1.4 Growing use of particle therapy for cancer treatment
5.2.2 KEY MARKET RESTRAINTS
5.2.2.1 Lack of adequate healthcare infrastructure
5.2.2.2 Shortage of skilled oncologists/radiologists
5.2.2.3 Affordability and accessibility of treatment
5.2.2.4 Complex nature of radiotherapy
5.2.3 KEY MARKET OPPORTUNITIES
5.2.3.1 Rising healthcare expenditure across developing countries
5.2.3.2 Growing government and private investments to meet the increasing demand for cancer treatment
5.2.4 CHALLENGES
5.2.4.1 Difficulties in visualizing tumors during radiotherapy procedures
5.2.4.2 Risk of radiation exposure
5.3 PORTER’S FIVE FORCES ANALYSIS
5.3.1 OVERVIEW
TABLE 1 RADIOTHERAPY MARKET: PORTER’S FIVE FORCES ANALYSIS
5.3.2 THREAT OF NEW ENTRANTS
FIGURE 16 THREAT OF NEW ENTRANTS
5.3.3 THREAT OF SUBSTITUTES
FIGURE 17 THREAT OF SUBSTITUTES
5.3.4 BARGAINING POWER OF SUPPLIERS
FIGURE 18 BARGAINING POWER OF SUPPLIERS
5.3.5 BARGAINING POWER OF BUYERS
FIGURE 19 BARGAINING POWER OF BUYERS
5.3.6 DEGREE OF COMPETITION
FIGURE 20 DEGREE OF COMPETITION
5.4 REGULATORY SCENARIO
5.4.1 US
TABLE 2 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.4.2 EUROPE
5.4.3 JAPAN
TABLE 3 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
5.4.4 EMERGING COUNTRIES
5.5 REIMBURSEMENT SCENARIO
TABLE 4 REIMBURSEMENT CODES FOR RADIOTHERAPY AND RELATED PROCEDURES
5.6 ECOSYSTEM COVERAGE
5.7 VALUE CHAIN ANALYSIS
5.8 COVID-19 IMPACT ON THE RADIOTHERAPY MARKET
5.9 PRICING ANALYSIS
5.10 PATENT ANALYSIS
5.10.1 PATENT DETAILS
FIGURE 21 PATENT ANALYSIS, JANUARY 2011–MARCH 2021
6 RADIOTHERAPY MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 5 RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
6.2 EXTERNAL BEAM RADIOTHERAPY PRODUCTS
TABLE 6 EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 7 EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.1 LINEAR ACCELERATORS
TABLE 8 LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 9 LINEAR ACCELERATORS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.2 CONVENTIONAL LINEAR ACCELERATORS
6.2.2.1 Lower equipment and maintenance cost will drive the market for conventional LINACs
TABLE 10 CONVENTIONAL LINEAR ACCELERATORS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.3 STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINEAR ACCELERATORS
TABLE 11 STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 12 STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINEAR ACCELERATORS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.3.1 Cyberknife
6.2.3.1.1 CyberKnife offers a precise radiation delivery method with specialized tracking and robotic correction capabilities
TABLE 13 CYBERKNIFE MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.3.2 Gamma knife
6.2.3.2.1 Gamma Knife offers promising results for brain
metastasis patients
TABLE 14 GAMMA KNIFE MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.3.3 Tomotherapy
6.2.3.3.1 Continuous product development and launches adding
to the growth prospects of this market segment
TABLE 15 TOMOTHERAPY MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.4 PARTICLE THERAPY SYSTEMS
TABLE 16 PARTICLE THERAPY SYSTEMS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 17 PARTICLE THERAPY SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.4.1 Cyclotrons
6.2.4.1.1 Leading players in the particle therapy market mainly manufacture cyclotrons
TABLE 18 CYCLOTRONS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.4.2 Synchrotrons
6.2.4.2.1 Increasing investments for the development of synchrotron facilities are contributing to market growth
TABLE 19 SYNCHROTRONS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.4.3 Synchrocyclotrons
6.2.4.3.1 High space requirements of synchrocyclotrons are
limiting their widespread adoption
TABLE 20 SYNCHROCYCLOTRONS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.5 CONVENTIONAL COBALT-60 TELETHERAPY UNITS
6.2.5.1 High cost and risk of radiation exposure with cobalt-60 radio isotopes have hindered the growth of this segment
TABLE 21 CONVENTIONAL COBALT-60 TELETHERAPY UNITS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS
TABLE 22 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 23 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3.1 SEEDS
6.3.1.1 Adverse side-effects associated with seeds limit their adoption
TABLE 24 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY SEEDS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3.2 APPLICATORS
6.3.2.1 Manual applicators pose a high risk of radiation exposure
to the patients and staff
TABLE 25 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATORS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3.3 AFTERLOADERS
6.3.3.1 Modern afterloaders offer proper positioning and better control
of isotopes inside the body of patients
TABLE 26 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY AFTERLOADERS
MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3.4 IORT SYSTEMS
6.3.4.1 Growing adoption of electronic brachytherapy procedures to support the growth of this market segment
TABLE 27 IORT SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.4 SYSTEMIC RADIOTHERAPY
6.4.1 IOBENGUANE (I-131)
6.4.2 SAMARIUM-153
6.4.3 RHENIUM-186
6.4.4 OTHER SYSTEMIC RADIOTHERAPY PRODUCTS
7 RADIOTHERAPY MARKET, BY APPLICATION
7.1 INTRODUCTION
TABLE 28 RADIOTHERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
7.2 EXTERNAL BEAM RADIOTHERAPY APPLICATIONS
TABLE 29 EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 30 EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY REGION, 2019–2026 (USD MILLION)
7.2.1 PROSTATE CANCER
7.2.1.1 High incidence rate and efficiency of EBRT for prostate cancer treatment to drive the growth of this market segment
TABLE 31 EXTERNAL BEAM RADIOTHERAPY MARKET FOR PROSTATE CANCER, BY REGION, 2019–2026 (USD MILLION)
7.2.2 BREAST CANCER
7.2.2.1 Therapeutic benefits of EBRT for breast cancer over other treatments to drive the growth of this market segment
TABLE 32 EXTERNAL BEAM RADIOTHERAPY MARKET FOR BREAST CANCER, BY REGION, 2019–2026 (USD MILLION)
7.2.3 LUNG CANCER
7.2.3.1 Radiotherapy can be used as an adjuvant therapy with surgical procedures or chemotherapy or as a curative therapy for lung cancer
TABLE 33 EXTERNAL BEAM RADIOTHERAPY MARKET FOR LUNG CANCER, BY REGION, 2019–2026 (USD MILLION)
7.2.4 HEAD & NECK CANCER
7.2.4.1 Benefits of EBRT will increase its use in head and neck
cancer treatment
TABLE 34 EXTERNAL BEAM RADIOTHERAPY MARKET FOR HEAD & NECK CANCER, BY REGION, 2019–2026 (USD MILLION)
7.2.5 COLORECTAL CANCER
7.2.5.1 Availability of alternative therapeutic options to limit the growth
of this market segment
TABLE 35 EXTERNAL BEAM RADIOTHERAPY MARKET FOR COLORECTAL CANCER, BY REGION, 2019–2026 (USD MILLION)
7.2.6 OTHER CANCERS
TABLE 36 EXTERNAL BEAM RADIOTHERAPY MARKET FOR OTHER CANCERS, BY REGION, 2019–2026 (USD MILLION)
7.3 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS
TABLE 37 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 38 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY REGION, 2019–2026 (USD MILLION)
7.3.1 PROSTATE CANCER
7.3.1.1 Precision and rapidity of brachytherapy in prostate cancer treatment to drive the growth of this market segment
TABLE 39 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR PROSTATE CANCER, BY REGION, 2019–2026 (USD MILLION)
7.3.2 GYNECOLOGICAL CANCER
7.3.2.1 Availability of alternatives to hinder the adoption of brachytherapy
in gynecological cancer treatment
TABLE 40 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR GYNECOLOGICAL CANCER, BY REGION, 2019–2026 (USD MILLION)
7.3.3 BREAST CANCER
7.3.3.1 Precision and rapidity of brachytherapy treatment are driving
its use in breast cancer applications
TABLE 41 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR
BREAST CANCER, BY REGION, 2019–2026 (USD MILLION)
7.3.4 CERVICAL CANCER
7.3.4.1 Brachytherapy is an important part of the treatment of cervical cancer patients when radiation therapy is the primary choice of curative treatment
TABLE 42 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR CERVICAL CANCER, BY REGION, 2019–2026 (USD MILLION)
7.3.5 PENILE CANCER
7.3.5.1 Interstitial brachytherapy is the standard conservative therapy
for localized penile cancer
TABLE 43 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR PENILE CANCER, BY REGION, 2019–2026 (USD MILLION)
7.3.6 OTHER CANCERS
TABLE 44 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR OTHER CANCERS, BY REGION, 2019–2026 (USD MILLION)
8 RADIOTHERAPY MARKET, BY PROCEDURE
8.1 INTRODUCTION
TABLE 45 RADIOTHERAPY MARKET, BY PROCEDURE, 2019–2026 (USD MILLION)
8.2 EXTERNAL BEAM RADIOTHERAPY
TABLE 46 EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 47 EXTERNAL BEAM RADIOTHERAPY MARKET, BY REGION, 2019–2026 (USD MILLION)
8.3 IMAGE-GUIDED RADIOTHERAPY
TABLE 48 IMAGE-GUIDED RADIOTHERAPY MARKET, BY REGION, 2019–2026 (USD MILLION)
8.3.1 INTENSITY-MODULATED RADIOTHERAPY
8.3.1.1 The radiation intensity of each beam in IMRT is controlled, and the beam shape changes throughout each treatment.
TABLE 49 INTENSITY-MODULATED RADIOTHERAPY MARKET, BY REGION, 2019–2026 (USD MILLION)
8.3.2 3D CONFORMAL RADIOTHERAPY
8.3.2.1 Multiple beams with 3D-CRT allow precise radiation conforming
to the tumor shape and size
TABLE 50 3D CONFORMAL RADIOTHERAPY MARKET, BY REGION, 2019–2026 (USD MILLION)
8.3.3 STEREOTACTIC THERAPY
8.3.3.1 Stereotactic therapy offers a minimally invasive alternative to ablation surgeries
TABLE 51 STEREOTACTIC THERAPY MARKET, BY REGION, 2019–2026 (USD MILLION)
8.3.4 PARTICLE THERAPY
8.3.4.1 Adoption of particle therapy as the primary mode of cancer
treatment is increasing
TABLE 52 PARTICLE THERAPY MARKET, BY REGION, 2019–2026 (USD MILLION)
8.4 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY
TABLE 53 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 54 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY REGION, 2019–2026 (USD MILLION)
8.4.1 HIGH-DOSE-RATE BRACHYTHERAPY
8.4.1.1 Electronic brachytherapy is one of the recent advancements
in this technique
TABLE 55 HIGH-DOSE-RATE BRACHYTHERAPY MARKET, BY REGION, 2019–2026 (USD MILLION)
8.4.2 LOW-DOSE-RATE BRACHYTHERAPY
8.4.2.1 Lower risk of radiation exposure to the surrounding tissues
to support the growth of this market segment
TABLE 56 LOW-DOSE-RATE BRACHYTHERAPY MARKET, BY REGION, 2019–2026 (USD MILLION)
8.4.3 PULSED-DOSE-RATE BRACHYTHERAPY
8.4.3.1 Pulsed-dose-rate brachytherapy combines the advantages
of HDR and LDR brachytherapy
TABLE 57 PULSED-DOSE-RATE BRACHYTHERAPY MARKET, BY REGION, 2019–2026 (USD MILLION)
8.5 SYSTEMIC RADIOTHERAPY
8.5.1 INTRAVENOUS RADIOTHERAPY
8.5.2 ORAL RADIOTHERAPY
8.5.3 INSTILLATION RADIOTHERAPY
9 RADIOTHERAPY MARKET, BY END USER
9.1 INTRODUCTION
TABLE 58 RADIOTHERAPY MARKET, BY END USER, 2019–2026 (USD MILLION)
9.2 HOSPITALS
9.2.1 INCREASING NUMBER OF SUPPLY DEALS OF ADVANCED RADIOTHERAPY PRODUCTS BETWEEN COMPANIES AND HOSPITALS TO DRIVE
MARKET GROWTH
TABLE 59 RADIOTHERAPY MARKET FOR HOSPITALS, BY REGION, 2019–2026 (USD MILLION)
9.3 INDEPENDENT RADIOTHERAPY CENTERS
9.3.1 RISING CONSOLIDATION OF HEALTHCARE NETWORKS IS CHALLENGING
THE GROWTH OF FREE-STANDING RADIOTHERAPY CENTERS
TABLE 60 RADIOTHERAPY MARKET FOR INDEPENDENT RADIOTHERAPY CENTERS, BY REGION, 2019–2026 (USD MILLION)
10 RADIOTHERAPY MARKET, BY REGION
10.1 INTRODUCTION
TABLE 61 RADIOTHERAPY MARKET, BY REGION, 2019–2026 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 22 NORTH AMERICA: RADIOTHERAPY MARKET SNAPSHOT
TABLE 62 NORTH AMERICA: RADIOTHERAPY MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 63 NORTH AMERICA: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 64 NORTH AMERICA: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 65 NORTH AMERICA: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 66 NORTH AMERICA: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 67 NORTH AMERICA: PARTICLE THERAPY SYSTEMS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 68 NORTH AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 69 NORTH AMERICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 70 NORTH AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 71 NORTH AMERICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY APPLICATION, 019–2026 (USD MILLION)
TABLE 72 NORTH AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 73 NORTH AMERICA: RADIOTHERAPY MARKET, BY END USER, 2019–2026 (USD MILLION)
10.2.1 US
10.2.1.1 Changes in the reimbursement scenario to drive market
growth in the US
TABLE 74 US: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 75 US: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 76 US: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 77 US: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Increasing incidence of cancer to drive market growth in Canada
TABLE 78 CANADA: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 79 CANADA: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 80 CANADA: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 81 CANADA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
10.3 EUROPE
TABLE 82 EUROPE: RADIOTHERAPY MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 83 EUROPE: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 84 EUROPE: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 85 EUROPE: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 86 EUROPE: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 87 EUROPE: PARTICLE THERAPY SYSTEMS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 88 EUROPE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 89 EUROPE: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 90 EUROPE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 91 EUROPE: EXTERNAL BEAM RADIOTHERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 92 EUROPE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 93 EUROPE: RADIOTHERAPY MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Germany is the largest market for radiotherapy in Europe
TABLE 94 GERMANY: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 95 GERMANY: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 96 GERMANY: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 97 GERMANY: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
10.3.2 FRANCE
10.3.2.1 High healthcare expenditure in France to drive market growth
TABLE 98 FRANCE: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 99 FRANCE: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 100 FRANCE: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 101 FRANCE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
10.3.3 UK
10.3.3.1 Increasing prevalence of cancer to drive market growth in the UK
TABLE 102 UK: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 103 UK: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 104 UK: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 105 UK: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
10.3.4 SPAIN
10.3.4.1 Increasing number of conferences and government funding for cancer research to drive market growth in Spain
TABLE 106 SPAIN: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 107 SPAIN: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 108 SPAIN: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 109 SPAIN: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
10.3.5 ITALY
10.3.5.1 Increasing awareness activities to support market growth
TABLE 110 ITALY: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 111 ITALY: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 112 ITALY: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 113 ITALY: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 114 ROE: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 115 ROE: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 116 ROE: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 117 ROE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 23 ASIA PACIFIC: RADIOTHERAPY MARKET SNAPSHOT
TABLE 118 ASIA PACIFIC: RADIOTHERAPY MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 119 ASIA PACIFIC: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 120 ASIA PACIFIC: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 121 ASIA PACIFIC: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 122 ASIA PACIFIC: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 123 ASIA PACIFIC: PARTICLE THERAPY SYSTEMS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 124 ASIA PACIFIC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 125 ASIA PACIFIC: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 126 ASIA PACIFIC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 127 ASIA PACIFIC: EXTERNAL BEAM RADIOTHERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 128 ASIA PACIFIC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 129 ASIA PACIFIC: RADIOTHERAPY MARKET, BY END USER, 2019–2026 (USD MILLION)
10.4.1 JAPAN
10.4.1.1 Rising geriatric population and subsequent increase in the prevalence of cancer to drive market growth in Japan
TABLE 130 JAPAN: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 131 JAPAN: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 132 JAPAN: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 133 JAPAN: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
10.4.2 CHINA
10.4.2.1 Increasing number of strategic partnerships and supply
deals to drive market growth
TABLE 134 CHINA: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 135 CHINA: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 136 CHINA: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 137 CHINA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
10.4.3 INDIA
10.4.3.1 High need for radiotherapy systems in the country is expected
to offer growth opportunities to market players
TABLE 138 INDIA: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 139 INDIA: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 140 INDIA: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 141 INDIA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
10.4.4 SOUTH KOREA
10.4.4.1 Increasing incidence of cancer to drive market growth in South Korea
TABLE 142 SOUTH KOREA: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 143 SOUTH KOREA: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 144 SOUTH KOREA: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 145 SOUTH KOREA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
10.4.5 AUSTRALIA
10.4.5.1 Increasing prevalence of cancer to drive market growth in Australia
TABLE 146 AUSTRALIA: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 147 AUSTRALIA: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 148 AUSTRALIA: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 149 AUSTRALIA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
10.4.6 REST OF ASIA PACIFIC
TABLE 150 ROAPAC: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 151 ROAPAC: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 152 ROAPAC: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 153 ROAPAC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
10.5 LATIN AMERICA
TABLE 154 LATIN AMERICA: RADIOTHERAPY MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 155 LATIN AMERICA: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 156 LATIN AMERICA: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 157 LATIN AMERICA: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 158 LATIN AMERICA: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 159 LATIN AMERICA: PARTICLE THERAPY SYSTEMS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 160 LATIN AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 161 LATIN AMERICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 162 LATIN AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 163 LATIN AMERICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 164 LATIN AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 165 LATIN AMERICA: RADIOTHERAPY MARKET, BY END USER, 2019–2026 (USD MILLION)
10.5.1 BRAZIL
10.5.1.1 Increasing cancer incidence to drive market growth in Brazil
TABLE 166 BRAZIL: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 167 BRAZIL: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 168 BRAZIL: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 169 BRAZIL: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
10.5.2 MEXICO
10.5.2.1 Increasing awareness programs fueling market growth in Mexico
TABLE 170 MEXICO: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 171 MEXICO: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 172 MEXICO: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 173 MEXICO: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
10.5.3 REST OF LATIN AMERICA
TABLE 174 ROLA: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 175 ROLA: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 176 ROLA: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 177 ROLA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
10.6 MIDDLE EAST & AFRICA
10.6.1 IMPROVING HEALTHCARE INFRASTRUCTURE AND INCREASING PUBLIC-PRIVATE INVESTMENTS TO DRIVE MARKET GROWTH IN THE MEA
TABLE 178 MEA: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 179 MEA: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 180 MEA: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 181 MEA: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 182 MEA: PARTICLE THERAPY SYSTEMS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 183 MEA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 184 MEA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 185 MEA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 186 MEA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 187 MEA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 188 MEA: RADIOTHERAPY MARKET, BY END USER, 2019–2026 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
FIGURE 24 KEY DEVELOPMENTS IN THE RADIOTHERAPY MARKET
(JANUARY 2018 TO MAY 2021)
11.2 MARKET SHARE ANALYSIS
11.2.1 GLOBAL RADIOTHERAPY MARKET SHARE ANALYSIS (2020)
FIGURE 25 GLOBAL RADIOTHERAPY MARKET SHARE ANALYSIS, BY KEY PLAYER (2020)
11.3 COMPANY EVALUATION QUADRANT
11.3.1 STARS
11.3.2 EMERGING LEADERS
11.3.3 PERVASIVE PLAYERS
11.3.4 PARTICIPANTS
FIGURE 26 RADIOTHERAPY MARKET: COMPETITIVE LEADERSHIP MAPPING (2020)
FIGURE 27 RADIOTHERAPY MARKET: COMPETITIVE LEADERSHIP MAPPING FOR SMES/START-UPS (2020)
11.4 COMPETITIVE SCENARIO
11.4.1 PRODUCT LAUNCHES AND APPROVALS
TABLE 189 RADIOTHERAPY MARKET: KEY PRODUCT LAUNCHES AND APPROVALS, JANUARY 2018 TO MAY 2021
11.4.2 EXPANSIONS
TABLE 190 RADIOTHERAPY MARKET: KEY EXPANSIONS, JANUARY 2018 TO MAY 2021
11.4.3 DEALS
TABLE 191 RADIOTHERAPY MARKET: KEY DEALS, JANUARY 2018 TO MAY 2021
12 COMPANY PROFILES
12.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, MnM view)*
12.1.1 VARIAN MEDICAL SYSTEMS, INC.
TABLE 192 VARIAN MEDICAL SYSTEMS, INC.: BUSINESS OVERVIEW
FIGURE 28 VARIAN MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT
12.1.2 ELEKTA AB
TABLE 193 ELEKTA AB: BUSINESS OVERVIEW
FIGURE 29 ELEKTA AB: COMPANY SNAPSHOT
12.1.3 ACCURAY INCORPORATED
TABLE 194 ACCURAY INCORPORATED: BUSINESS OVERVIEW
FIGURE 30 ACCURAY INCORPORATED: COMPANY SNAPSHOT
12.1.4 BECTON, DICKINSON AND COMPANY
TABLE 195 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
FIGURE 31 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
12.1.5 IBA WORLDWIDE
TABLE 196 IBA WORLDWIDE: BUSINESS OVERVIEW
FIGURE 32 IBA WORLDWIDE: COMPANY SNAPSHOT
12.1.6 VIEWRAY, INC.
TABLE 197 VIEWRAY, INC.: BUSINESS OVERVIEW
FIGURE 33 VIEWRAY, INC.: COMPANY SNAPSHOT
12.1.7 ISORAY MEDICAL
TABLE 198 ISORAY MEDICAL: BUSINESS OVERVIEW
FIGURE 34 ISORAY MEDICAL, INC.: COMPANY SNAPSHOT
12.1.8 HITACHI LTD.
TABLE 199 HITACHI LTD.: BUSINESS OVERVIEW
FIGURE 35 HITACHI LTD.: COMPANY SNAPSHOT
12.1.9 PANACEA MEDICAL TECHNOLOGIES PVT. LTD.
TABLE 200 PANACEA MEDICAL TECHNOLOGIES PVT. LTD.: BUSINESS OVERVIEW
12.1.10 PROVISION HEALTHCARE
TABLE 201 PROVISION HEALTHCARE: BUSINESS OVERVIEW
12.1.11 MEVION MEDICAL SYSTEMS
TABLE 202 MEVION MEDICAL SYSTEMS: BUSINESS OVERVIEW
12.1.12 OPTIVUS PROTON THERAPY, INC.
TABLE 203 OPTIVUS PROTON THERAPY: BUSINESS OVERVIEW
12.1.13 P-CURE
TABLE 204 P-CURE: BUSINESS OVERVIEW
12.1.14 SUMITOMO HEAVY INDUSTRIES LTD.
TABLE 205 SUMITOMO HEAVY INDUSTRIES LTD.: BUSINESS OVERVIEW
FIGURE 36 SUMITOMO HEAVY INDUSTRIES: COMPANY SNAPSHOT
TABLE 206 THERAGENICS CORPORATION: BUSINESS OVERVIEW
12.1.15 ZEISS GROUP
TABLE 207 ZEISS GROUP: BUSINESS OVERVIEW
FIGURE 37 ZEISS GROUP: COMPANY SNAPSHOT
12.2 OTHER PLAYERS
12.2.1 INTRAOP MEDICAL, INC.
12.2.2 ICAD, INC.
12.2.3 ECKERT & ZIEGLER
12.2.4 SENSUS HEALTHCARE
12.2.5 S.I.T SORDINA IORT TECHNOLOGIES S.P.A.
*Details on Business Overview, Products Offered, Recent Developments, MnM view might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY USED FOR THE STUDY
1.5 MARKET STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 2 BREAKDOWN OF PRIMARIES: RADIOTHERAPY MARKET
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
2.2.2 USAGE-BASED MARKET ESTIMATION
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: GLOBAL RADIOTHERAPY MARKET
2.2.3 PRIMARY RESEARCH VALIDATION
2.3 DATA TRIANGULATION
FIGURE 5 DATA TRIANGULATION
2.4 RESEARCH ASSUMPTIONS
2.5 RESEARCH LIMITATIONS
3 EXECUTIVE SUMMARY
FIGURE 6 RADIOTHERAPY MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
FIGURE 7 EXTERNAL BEAM RADIOTHERAPY MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
FIGURE 8 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PROCEDURE, 2021 VS. 2026 (USD MILLION)
FIGURE 9 RADIOTHERAPY MARKET SHARE, BY END USER, 2021 VS. 2026
FIGURE 10 GEOGRAPHICAL SNAPSHOT OF THE RADIOTHERAPY MARKET
4 PREMIUM INSIGHTS
4.1 RADIOTHERAPY MARKET OVERVIEW
FIGURE 11 RISING CANCER PREVALENCE ACROSS THE GLOBE TO DRIVE THE
GROWTH OF THE RADIOTHERAPY MARKET
4.2 EUROPE: EXTERNAL BEAM RADIOTHERAPY MARKET, BY PRODUCT AND REGION
FIGURE 12 LINER ACCELERATORS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE
OF THE EUROPEAN MARKET
4.3 NORTH AMERICA: INTERNAL BEAM RADIOTHERAPY MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
FIGURE 13 PROSTATE CANCER TREATMENT IS THE LARGEST APPLICATION OF
INTERNAL BEAM RADIOTHERAPY IN NORTH AMERICA
4.4 GEOGRAPHIC SNAPSHOT OF THE RADIOTHERAPY MARKET
FIGURE 14 CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 15 RADIOTHERAPY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Technological advancements
5.2.1.2 Expansion of the target patient population
5.2.1.3 Increasing number of conferences and symposia focusing on spreading awareness about the benefits of radiotherapy
5.2.1.4 Growing use of particle therapy for cancer treatment
5.2.2 KEY MARKET RESTRAINTS
5.2.2.1 Lack of adequate healthcare infrastructure
5.2.2.2 Shortage of skilled oncologists/radiologists
5.2.2.3 Affordability and accessibility of treatment
5.2.2.4 Complex nature of radiotherapy
5.2.3 KEY MARKET OPPORTUNITIES
5.2.3.1 Rising healthcare expenditure across developing countries
5.2.3.2 Growing government and private investments to meet the increasing demand for cancer treatment
5.2.4 CHALLENGES
5.2.4.1 Difficulties in visualizing tumors during radiotherapy procedures
5.2.4.2 Risk of radiation exposure
5.3 PORTER’S FIVE FORCES ANALYSIS
5.3.1 OVERVIEW
TABLE 1 RADIOTHERAPY MARKET: PORTER’S FIVE FORCES ANALYSIS
5.3.2 THREAT OF NEW ENTRANTS
FIGURE 16 THREAT OF NEW ENTRANTS
5.3.3 THREAT OF SUBSTITUTES
FIGURE 17 THREAT OF SUBSTITUTES
5.3.4 BARGAINING POWER OF SUPPLIERS
FIGURE 18 BARGAINING POWER OF SUPPLIERS
5.3.5 BARGAINING POWER OF BUYERS
FIGURE 19 BARGAINING POWER OF BUYERS
5.3.6 DEGREE OF COMPETITION
FIGURE 20 DEGREE OF COMPETITION
5.4 REGULATORY SCENARIO
5.4.1 US
TABLE 2 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.4.2 EUROPE
5.4.3 JAPAN
TABLE 3 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
5.4.4 EMERGING COUNTRIES
5.5 REIMBURSEMENT SCENARIO
TABLE 4 REIMBURSEMENT CODES FOR RADIOTHERAPY AND RELATED PROCEDURES
5.6 ECOSYSTEM COVERAGE
5.7 VALUE CHAIN ANALYSIS
5.8 COVID-19 IMPACT ON THE RADIOTHERAPY MARKET
5.9 PRICING ANALYSIS
5.10 PATENT ANALYSIS
5.10.1 PATENT DETAILS
FIGURE 21 PATENT ANALYSIS, JANUARY 2011–MARCH 2021
6 RADIOTHERAPY MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 5 RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
6.2 EXTERNAL BEAM RADIOTHERAPY PRODUCTS
TABLE 6 EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 7 EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.1 LINEAR ACCELERATORS
TABLE 8 LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 9 LINEAR ACCELERATORS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.2 CONVENTIONAL LINEAR ACCELERATORS
6.2.2.1 Lower equipment and maintenance cost will drive the market for conventional LINACs
TABLE 10 CONVENTIONAL LINEAR ACCELERATORS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.3 STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINEAR ACCELERATORS
TABLE 11 STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 12 STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINEAR ACCELERATORS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.3.1 Cyberknife
6.2.3.1.1 CyberKnife offers a precise radiation delivery method with specialized tracking and robotic correction capabilities
TABLE 13 CYBERKNIFE MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.3.2 Gamma knife
6.2.3.2.1 Gamma Knife offers promising results for brain
metastasis patients
TABLE 14 GAMMA KNIFE MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.3.3 Tomotherapy
6.2.3.3.1 Continuous product development and launches adding
to the growth prospects of this market segment
TABLE 15 TOMOTHERAPY MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.4 PARTICLE THERAPY SYSTEMS
TABLE 16 PARTICLE THERAPY SYSTEMS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 17 PARTICLE THERAPY SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.4.1 Cyclotrons
6.2.4.1.1 Leading players in the particle therapy market mainly manufacture cyclotrons
TABLE 18 CYCLOTRONS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.4.2 Synchrotrons
6.2.4.2.1 Increasing investments for the development of synchrotron facilities are contributing to market growth
TABLE 19 SYNCHROTRONS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.4.3 Synchrocyclotrons
6.2.4.3.1 High space requirements of synchrocyclotrons are
limiting their widespread adoption
TABLE 20 SYNCHROCYCLOTRONS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.5 CONVENTIONAL COBALT-60 TELETHERAPY UNITS
6.2.5.1 High cost and risk of radiation exposure with cobalt-60 radio isotopes have hindered the growth of this segment
TABLE 21 CONVENTIONAL COBALT-60 TELETHERAPY UNITS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS
TABLE 22 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 23 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3.1 SEEDS
6.3.1.1 Adverse side-effects associated with seeds limit their adoption
TABLE 24 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY SEEDS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3.2 APPLICATORS
6.3.2.1 Manual applicators pose a high risk of radiation exposure
to the patients and staff
TABLE 25 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATORS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3.3 AFTERLOADERS
6.3.3.1 Modern afterloaders offer proper positioning and better control
of isotopes inside the body of patients
TABLE 26 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY AFTERLOADERS
MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3.4 IORT SYSTEMS
6.3.4.1 Growing adoption of electronic brachytherapy procedures to support the growth of this market segment
TABLE 27 IORT SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.4 SYSTEMIC RADIOTHERAPY
6.4.1 IOBENGUANE (I-131)
6.4.2 SAMARIUM-153
6.4.3 RHENIUM-186
6.4.4 OTHER SYSTEMIC RADIOTHERAPY PRODUCTS
7 RADIOTHERAPY MARKET, BY APPLICATION
7.1 INTRODUCTION
TABLE 28 RADIOTHERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
7.2 EXTERNAL BEAM RADIOTHERAPY APPLICATIONS
TABLE 29 EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 30 EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY REGION, 2019–2026 (USD MILLION)
7.2.1 PROSTATE CANCER
7.2.1.1 High incidence rate and efficiency of EBRT for prostate cancer treatment to drive the growth of this market segment
TABLE 31 EXTERNAL BEAM RADIOTHERAPY MARKET FOR PROSTATE CANCER, BY REGION, 2019–2026 (USD MILLION)
7.2.2 BREAST CANCER
7.2.2.1 Therapeutic benefits of EBRT for breast cancer over other treatments to drive the growth of this market segment
TABLE 32 EXTERNAL BEAM RADIOTHERAPY MARKET FOR BREAST CANCER, BY REGION, 2019–2026 (USD MILLION)
7.2.3 LUNG CANCER
7.2.3.1 Radiotherapy can be used as an adjuvant therapy with surgical procedures or chemotherapy or as a curative therapy for lung cancer
TABLE 33 EXTERNAL BEAM RADIOTHERAPY MARKET FOR LUNG CANCER, BY REGION, 2019–2026 (USD MILLION)
7.2.4 HEAD & NECK CANCER
7.2.4.1 Benefits of EBRT will increase its use in head and neck
cancer treatment
TABLE 34 EXTERNAL BEAM RADIOTHERAPY MARKET FOR HEAD & NECK CANCER, BY REGION, 2019–2026 (USD MILLION)
7.2.5 COLORECTAL CANCER
7.2.5.1 Availability of alternative therapeutic options to limit the growth
of this market segment
TABLE 35 EXTERNAL BEAM RADIOTHERAPY MARKET FOR COLORECTAL CANCER, BY REGION, 2019–2026 (USD MILLION)
7.2.6 OTHER CANCERS
TABLE 36 EXTERNAL BEAM RADIOTHERAPY MARKET FOR OTHER CANCERS, BY REGION, 2019–2026 (USD MILLION)
7.3 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS
TABLE 37 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 38 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY REGION, 2019–2026 (USD MILLION)
7.3.1 PROSTATE CANCER
7.3.1.1 Precision and rapidity of brachytherapy in prostate cancer treatment to drive the growth of this market segment
TABLE 39 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR PROSTATE CANCER, BY REGION, 2019–2026 (USD MILLION)
7.3.2 GYNECOLOGICAL CANCER
7.3.2.1 Availability of alternatives to hinder the adoption of brachytherapy
in gynecological cancer treatment
TABLE 40 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR GYNECOLOGICAL CANCER, BY REGION, 2019–2026 (USD MILLION)
7.3.3 BREAST CANCER
7.3.3.1 Precision and rapidity of brachytherapy treatment are driving
its use in breast cancer applications
TABLE 41 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR
BREAST CANCER, BY REGION, 2019–2026 (USD MILLION)
7.3.4 CERVICAL CANCER
7.3.4.1 Brachytherapy is an important part of the treatment of cervical cancer patients when radiation therapy is the primary choice of curative treatment
TABLE 42 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR CERVICAL CANCER, BY REGION, 2019–2026 (USD MILLION)
7.3.5 PENILE CANCER
7.3.5.1 Interstitial brachytherapy is the standard conservative therapy
for localized penile cancer
TABLE 43 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR PENILE CANCER, BY REGION, 2019–2026 (USD MILLION)
7.3.6 OTHER CANCERS
TABLE 44 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR OTHER CANCERS, BY REGION, 2019–2026 (USD MILLION)
8 RADIOTHERAPY MARKET, BY PROCEDURE
8.1 INTRODUCTION
TABLE 45 RADIOTHERAPY MARKET, BY PROCEDURE, 2019–2026 (USD MILLION)
8.2 EXTERNAL BEAM RADIOTHERAPY
TABLE 46 EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 47 EXTERNAL BEAM RADIOTHERAPY MARKET, BY REGION, 2019–2026 (USD MILLION)
8.3 IMAGE-GUIDED RADIOTHERAPY
TABLE 48 IMAGE-GUIDED RADIOTHERAPY MARKET, BY REGION, 2019–2026 (USD MILLION)
8.3.1 INTENSITY-MODULATED RADIOTHERAPY
8.3.1.1 The radiation intensity of each beam in IMRT is controlled, and the beam shape changes throughout each treatment.
TABLE 49 INTENSITY-MODULATED RADIOTHERAPY MARKET, BY REGION, 2019–2026 (USD MILLION)
8.3.2 3D CONFORMAL RADIOTHERAPY
8.3.2.1 Multiple beams with 3D-CRT allow precise radiation conforming
to the tumor shape and size
TABLE 50 3D CONFORMAL RADIOTHERAPY MARKET, BY REGION, 2019–2026 (USD MILLION)
8.3.3 STEREOTACTIC THERAPY
8.3.3.1 Stereotactic therapy offers a minimally invasive alternative to ablation surgeries
TABLE 51 STEREOTACTIC THERAPY MARKET, BY REGION, 2019–2026 (USD MILLION)
8.3.4 PARTICLE THERAPY
8.3.4.1 Adoption of particle therapy as the primary mode of cancer
treatment is increasing
TABLE 52 PARTICLE THERAPY MARKET, BY REGION, 2019–2026 (USD MILLION)
8.4 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY
TABLE 53 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 54 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY REGION, 2019–2026 (USD MILLION)
8.4.1 HIGH-DOSE-RATE BRACHYTHERAPY
8.4.1.1 Electronic brachytherapy is one of the recent advancements
in this technique
TABLE 55 HIGH-DOSE-RATE BRACHYTHERAPY MARKET, BY REGION, 2019–2026 (USD MILLION)
8.4.2 LOW-DOSE-RATE BRACHYTHERAPY
8.4.2.1 Lower risk of radiation exposure to the surrounding tissues
to support the growth of this market segment
TABLE 56 LOW-DOSE-RATE BRACHYTHERAPY MARKET, BY REGION, 2019–2026 (USD MILLION)
8.4.3 PULSED-DOSE-RATE BRACHYTHERAPY
8.4.3.1 Pulsed-dose-rate brachytherapy combines the advantages
of HDR and LDR brachytherapy
TABLE 57 PULSED-DOSE-RATE BRACHYTHERAPY MARKET, BY REGION, 2019–2026 (USD MILLION)
8.5 SYSTEMIC RADIOTHERAPY
8.5.1 INTRAVENOUS RADIOTHERAPY
8.5.2 ORAL RADIOTHERAPY
8.5.3 INSTILLATION RADIOTHERAPY
9 RADIOTHERAPY MARKET, BY END USER
9.1 INTRODUCTION
TABLE 58 RADIOTHERAPY MARKET, BY END USER, 2019–2026 (USD MILLION)
9.2 HOSPITALS
9.2.1 INCREASING NUMBER OF SUPPLY DEALS OF ADVANCED RADIOTHERAPY PRODUCTS BETWEEN COMPANIES AND HOSPITALS TO DRIVE
MARKET GROWTH
TABLE 59 RADIOTHERAPY MARKET FOR HOSPITALS, BY REGION, 2019–2026 (USD MILLION)
9.3 INDEPENDENT RADIOTHERAPY CENTERS
9.3.1 RISING CONSOLIDATION OF HEALTHCARE NETWORKS IS CHALLENGING
THE GROWTH OF FREE-STANDING RADIOTHERAPY CENTERS
TABLE 60 RADIOTHERAPY MARKET FOR INDEPENDENT RADIOTHERAPY CENTERS, BY REGION, 2019–2026 (USD MILLION)
10 RADIOTHERAPY MARKET, BY REGION
10.1 INTRODUCTION
TABLE 61 RADIOTHERAPY MARKET, BY REGION, 2019–2026 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 22 NORTH AMERICA: RADIOTHERAPY MARKET SNAPSHOT
TABLE 62 NORTH AMERICA: RADIOTHERAPY MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 63 NORTH AMERICA: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 64 NORTH AMERICA: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 65 NORTH AMERICA: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 66 NORTH AMERICA: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 67 NORTH AMERICA: PARTICLE THERAPY SYSTEMS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 68 NORTH AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 69 NORTH AMERICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 70 NORTH AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 71 NORTH AMERICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY APPLICATION, 019–2026 (USD MILLION)
TABLE 72 NORTH AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 73 NORTH AMERICA: RADIOTHERAPY MARKET, BY END USER, 2019–2026 (USD MILLION)
10.2.1 US
10.2.1.1 Changes in the reimbursement scenario to drive market
growth in the US
TABLE 74 US: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 75 US: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 76 US: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 77 US: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Increasing incidence of cancer to drive market growth in Canada
TABLE 78 CANADA: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 79 CANADA: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 80 CANADA: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 81 CANADA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
10.3 EUROPE
TABLE 82 EUROPE: RADIOTHERAPY MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 83 EUROPE: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 84 EUROPE: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 85 EUROPE: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 86 EUROPE: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 87 EUROPE: PARTICLE THERAPY SYSTEMS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 88 EUROPE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 89 EUROPE: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 90 EUROPE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 91 EUROPE: EXTERNAL BEAM RADIOTHERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 92 EUROPE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 93 EUROPE: RADIOTHERAPY MARKET, BY END USER, 2019–2026 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Germany is the largest market for radiotherapy in Europe
TABLE 94 GERMANY: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 95 GERMANY: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 96 GERMANY: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 97 GERMANY: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
10.3.2 FRANCE
10.3.2.1 High healthcare expenditure in France to drive market growth
TABLE 98 FRANCE: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 99 FRANCE: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 100 FRANCE: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 101 FRANCE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
10.3.3 UK
10.3.3.1 Increasing prevalence of cancer to drive market growth in the UK
TABLE 102 UK: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 103 UK: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 104 UK: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 105 UK: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
10.3.4 SPAIN
10.3.4.1 Increasing number of conferences and government funding for cancer research to drive market growth in Spain
TABLE 106 SPAIN: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 107 SPAIN: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 108 SPAIN: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 109 SPAIN: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
10.3.5 ITALY
10.3.5.1 Increasing awareness activities to support market growth
TABLE 110 ITALY: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 111 ITALY: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 112 ITALY: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 113 ITALY: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 114 ROE: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 115 ROE: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 116 ROE: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 117 ROE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 23 ASIA PACIFIC: RADIOTHERAPY MARKET SNAPSHOT
TABLE 118 ASIA PACIFIC: RADIOTHERAPY MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 119 ASIA PACIFIC: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 120 ASIA PACIFIC: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 121 ASIA PACIFIC: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 122 ASIA PACIFIC: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 123 ASIA PACIFIC: PARTICLE THERAPY SYSTEMS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 124 ASIA PACIFIC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 125 ASIA PACIFIC: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 126 ASIA PACIFIC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 127 ASIA PACIFIC: EXTERNAL BEAM RADIOTHERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 128 ASIA PACIFIC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 129 ASIA PACIFIC: RADIOTHERAPY MARKET, BY END USER, 2019–2026 (USD MILLION)
10.4.1 JAPAN
10.4.1.1 Rising geriatric population and subsequent increase in the prevalence of cancer to drive market growth in Japan
TABLE 130 JAPAN: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 131 JAPAN: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 132 JAPAN: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 133 JAPAN: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
10.4.2 CHINA
10.4.2.1 Increasing number of strategic partnerships and supply
deals to drive market growth
TABLE 134 CHINA: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 135 CHINA: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 136 CHINA: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 137 CHINA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
10.4.3 INDIA
10.4.3.1 High need for radiotherapy systems in the country is expected
to offer growth opportunities to market players
TABLE 138 INDIA: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 139 INDIA: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 140 INDIA: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 141 INDIA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
10.4.4 SOUTH KOREA
10.4.4.1 Increasing incidence of cancer to drive market growth in South Korea
TABLE 142 SOUTH KOREA: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 143 SOUTH KOREA: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 144 SOUTH KOREA: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 145 SOUTH KOREA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
10.4.5 AUSTRALIA
10.4.5.1 Increasing prevalence of cancer to drive market growth in Australia
TABLE 146 AUSTRALIA: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 147 AUSTRALIA: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 148 AUSTRALIA: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 149 AUSTRALIA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
10.4.6 REST OF ASIA PACIFIC
TABLE 150 ROAPAC: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 151 ROAPAC: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 152 ROAPAC: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 153 ROAPAC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
10.5 LATIN AMERICA
TABLE 154 LATIN AMERICA: RADIOTHERAPY MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 155 LATIN AMERICA: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 156 LATIN AMERICA: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 157 LATIN AMERICA: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 158 LATIN AMERICA: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 159 LATIN AMERICA: PARTICLE THERAPY SYSTEMS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 160 LATIN AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 161 LATIN AMERICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 162 LATIN AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 163 LATIN AMERICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 164 LATIN AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 165 LATIN AMERICA: RADIOTHERAPY MARKET, BY END USER, 2019–2026 (USD MILLION)
10.5.1 BRAZIL
10.5.1.1 Increasing cancer incidence to drive market growth in Brazil
TABLE 166 BRAZIL: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 167 BRAZIL: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 168 BRAZIL: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 169 BRAZIL: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
10.5.2 MEXICO
10.5.2.1 Increasing awareness programs fueling market growth in Mexico
TABLE 170 MEXICO: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 171 MEXICO: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 172 MEXICO: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 173 MEXICO: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
10.5.3 REST OF LATIN AMERICA
TABLE 174 ROLA: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 175 ROLA: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 176 ROLA: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 177 ROLA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
10.6 MIDDLE EAST & AFRICA
10.6.1 IMPROVING HEALTHCARE INFRASTRUCTURE AND INCREASING PUBLIC-PRIVATE INVESTMENTS TO DRIVE MARKET GROWTH IN THE MEA
TABLE 178 MEA: RADIOTHERAPY MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 179 MEA: EXTERNAL BEAM RADIOTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 180 MEA: LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 181 MEA: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINEAR ACCELERATORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 182 MEA: PARTICLE THERAPY SYSTEMS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 183 MEA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 184 MEA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 185 MEA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 186 MEA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 187 MEA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 188 MEA: RADIOTHERAPY MARKET, BY END USER, 2019–2026 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
FIGURE 24 KEY DEVELOPMENTS IN THE RADIOTHERAPY MARKET
(JANUARY 2018 TO MAY 2021)
11.2 MARKET SHARE ANALYSIS
11.2.1 GLOBAL RADIOTHERAPY MARKET SHARE ANALYSIS (2020)
FIGURE 25 GLOBAL RADIOTHERAPY MARKET SHARE ANALYSIS, BY KEY PLAYER (2020)
11.3 COMPANY EVALUATION QUADRANT
11.3.1 STARS
11.3.2 EMERGING LEADERS
11.3.3 PERVASIVE PLAYERS
11.3.4 PARTICIPANTS
FIGURE 26 RADIOTHERAPY MARKET: COMPETITIVE LEADERSHIP MAPPING (2020)
FIGURE 27 RADIOTHERAPY MARKET: COMPETITIVE LEADERSHIP MAPPING FOR SMES/START-UPS (2020)
11.4 COMPETITIVE SCENARIO
11.4.1 PRODUCT LAUNCHES AND APPROVALS
TABLE 189 RADIOTHERAPY MARKET: KEY PRODUCT LAUNCHES AND APPROVALS, JANUARY 2018 TO MAY 2021
11.4.2 EXPANSIONS
TABLE 190 RADIOTHERAPY MARKET: KEY EXPANSIONS, JANUARY 2018 TO MAY 2021
11.4.3 DEALS
TABLE 191 RADIOTHERAPY MARKET: KEY DEALS, JANUARY 2018 TO MAY 2021
12 COMPANY PROFILES
12.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, MnM view)*
12.1.1 VARIAN MEDICAL SYSTEMS, INC.
TABLE 192 VARIAN MEDICAL SYSTEMS, INC.: BUSINESS OVERVIEW
FIGURE 28 VARIAN MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT
12.1.2 ELEKTA AB
TABLE 193 ELEKTA AB: BUSINESS OVERVIEW
FIGURE 29 ELEKTA AB: COMPANY SNAPSHOT
12.1.3 ACCURAY INCORPORATED
TABLE 194 ACCURAY INCORPORATED: BUSINESS OVERVIEW
FIGURE 30 ACCURAY INCORPORATED: COMPANY SNAPSHOT
12.1.4 BECTON, DICKINSON AND COMPANY
TABLE 195 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
FIGURE 31 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
12.1.5 IBA WORLDWIDE
TABLE 196 IBA WORLDWIDE: BUSINESS OVERVIEW
FIGURE 32 IBA WORLDWIDE: COMPANY SNAPSHOT
12.1.6 VIEWRAY, INC.
TABLE 197 VIEWRAY, INC.: BUSINESS OVERVIEW
FIGURE 33 VIEWRAY, INC.: COMPANY SNAPSHOT
12.1.7 ISORAY MEDICAL
TABLE 198 ISORAY MEDICAL: BUSINESS OVERVIEW
FIGURE 34 ISORAY MEDICAL, INC.: COMPANY SNAPSHOT
12.1.8 HITACHI LTD.
TABLE 199 HITACHI LTD.: BUSINESS OVERVIEW
FIGURE 35 HITACHI LTD.: COMPANY SNAPSHOT
12.1.9 PANACEA MEDICAL TECHNOLOGIES PVT. LTD.
TABLE 200 PANACEA MEDICAL TECHNOLOGIES PVT. LTD.: BUSINESS OVERVIEW
12.1.10 PROVISION HEALTHCARE
TABLE 201 PROVISION HEALTHCARE: BUSINESS OVERVIEW
12.1.11 MEVION MEDICAL SYSTEMS
TABLE 202 MEVION MEDICAL SYSTEMS: BUSINESS OVERVIEW
12.1.12 OPTIVUS PROTON THERAPY, INC.
TABLE 203 OPTIVUS PROTON THERAPY: BUSINESS OVERVIEW
12.1.13 P-CURE
TABLE 204 P-CURE: BUSINESS OVERVIEW
12.1.14 SUMITOMO HEAVY INDUSTRIES LTD.
TABLE 205 SUMITOMO HEAVY INDUSTRIES LTD.: BUSINESS OVERVIEW
FIGURE 36 SUMITOMO HEAVY INDUSTRIES: COMPANY SNAPSHOT
TABLE 206 THERAGENICS CORPORATION: BUSINESS OVERVIEW
12.1.15 ZEISS GROUP
TABLE 207 ZEISS GROUP: BUSINESS OVERVIEW
FIGURE 37 ZEISS GROUP: COMPANY SNAPSHOT
12.2 OTHER PLAYERS
12.2.1 INTRAOP MEDICAL, INC.
12.2.2 ICAD, INC.
12.2.3 ECKERT & ZIEGLER
12.2.4 SENSUS HEALTHCARE
12.2.5 S.I.T SORDINA IORT TECHNOLOGIES S.P.A.
*Details on Business Overview, Products Offered, Recent Developments, MnM view might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
